Abstract:Neuropathic pain can result from injury to, or disease of the nervous system. It is notoriously difficult to treat. Peripheral nerve injury promotes Schwann cell activation and invasion of immunocompetent cells into the site of injury, spinal cord and higher sensory structures such as thalamus and cingulate and sensory cortices. Various cytokines, chemokines, growth factors, monoamines and neuropeptides effect two-way signalling between neurons, glia and immune cells. This promotes sustained hyperexcitability and spontaneous activity in primary afferents that is crucial for onset and persistence of pain as well as misprocessing of sensory information in the spinal cord and supraspinal structures. Much of the current understanding of pain aetiology and identification of drug targets derives from studies of the consequences of peripheral nerve injury in rodent models. Although a vast amount of information has been forthcoming, the translation of this information into the clinical arena has been minimal. Few, if any, major therapeutic approaches have appeared since the mid 1990's. This may reflect failure to recognise differences in pain processing in males vs. females, differences in cellular responses to different types of injury and differences in pain processing in humans vs. animals. Basic science and clinical approaches which seek to bridge this knowledge gap include better assessment of pain in animal models, use of pain models which better emulate human disease, and stratification of human pain phenotypes according to quantitative assessment of signs and symptoms of disease. This can lead to more personalized and effective treatments for individual patients. Significance statement: There is an urgent need to find new treatments for neuropathic pain. Although classical animal models have revealed essential features of pain aetiology such as peripheral and central sensitization and some of the molecular and cellular mechanisms involved, they do not adequately model the multiplicity of disease states or injuries that may bring forth neuropathic pain in the clinic. This review seeks to integrate information from the multiplicity of disciplines that seek to understand neuropathic pain; including immunology, cell biology, electrophysiology and biophysics, anatomy, cell biology, neurology, molecular biology, pharmacology and behavioral science. Beyond this, it underlines ongoing refinements in basic science and clinical practice that will engender improved approaches to pain management.

Animal models of chronic pain: Advances and challenges for clinical translation

Translational pain assessment: could natural animal models be the missing link?

Advancing Pain Understanding and Drug Discovery: Insights from Preclinical Models and Recent Research Findings

The challenges of animal models of pain

IUPHAR review: Navigating the role of preclinical models in pain research

Animal Pain Models and Behavior Tests

Modulating Neural Circuits of Pain in Preclinical Models: Recent Insights for Future Therapeutics

Innovations and advances in modelling and measuring pain in animals

Molecular and Behavioral Changes in Nociception in a Novel Rat Model of Chronic Pancreatitis for the Study of Pain

Possible implications of animal models for the assessment of visceral pain

Potential of animal models for advancing the understanding and treatment of pain in Parkinson’s disease

Pain research in a petri dish? Advantages and limitations of neuro-glial primary cell cultures from structures of the nociceptive system

A systematic review of porcine models in translational pain research

How to study anxiety and depression in rodent models of chronic pain?

Neuropathic pain; what we know and what we should do about it

Central Nervous System Targets: Glial Cell Mechanisms in Chronic Pain

Animal Models of Diabetic Neuropathic Pain

Animal models in the study and treatment of orofacial pain

Animal models of pancreatitis: Can it be translated to human pain study?

Understanding the Molecular Mechanisms Underlying the Pathogenesis of Arthritis Pain Using Animal Models

Peripheral mechanisms of arthritic pain: A proposal to leverage large animals for in vitro studies